Abstract
Ribavirin (RBV) is an antiviral drug that is part of the current standard therapy for chronic hepatitis C (CHC). It is enzymatically converted to ribavirin triphosphate (RTP) that inhibits the activity of viral RNA polymerase, thereby preventing viral replication. However, one of its adverse effects includes hemolytic anemia that limits its application. The variant of ITPA (inosine triphosphatase), which dephosphorylates inosine triphosphate to inosine monophosphate, is a protective factor for RBV-induced anemia. RTP is an important metabolite required for ribavirin action. This study evaluated the time-dependent association of RTP concentrations in erythrocytes, RBV-induced toxicity, and virological response to RBV treatment for hepatitis C. A total of 28 Japanese patients with CHC were treated with RBV/peg-interferon/simeprevir or RBV/sofosbuvir and were genotyped for ITPA variants (rs1127354 and rs7270101). We measured RTP concentrations in erythrocytes in a total of 76 samples collected at 4, 8, and 12 weeks from the initiation of treatment. The ITPA rs1127354 variant was found in 7 patients. This was associated with significantly higher RTP concentrations in erythrocytes than in the wild-type patients (P < 0.001). Moreover...Continue Reading
References
Oct 18, 2002·Human Genetics·Satoshi SumiJohn A Duley
Dec 6, 2005·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yoichi InoueYukinao Kohda
Oct 13, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Chao-Hung HungChi-Sin Changchien
Jan 24, 2009·The Journal of Pharmacology and Experimental Therapeutics·Christopher J EndresJashvant D Unadkat
Feb 23, 2010·Nature·Jacques FellayDavid B Goldstein
Apr 14, 2010·Journal of Viral Hepatitis·C PedersenUNKNOWN NORDynamicIC Study Group
Jun 16, 2010·Gastroenterology·Alexander J ThompsonJohn G McHutchison
Jul 20, 2010·Gastroenterology·Hidenori OchiKazuaki Chayama
Mar 13, 2012·Therapeutic Drug Monitoring·Antonio DʼAvolioGiovanni Di Perri
Jul 20, 2012·Antiviral Therapy·Sheeja M Krishnan, Narendra M Dixit
Jul 16, 2013·Journal of Hepatology·Thomas-Matthias ScherzerPeter Ferenci
Feb 4, 2014·Journal of Hepatology·Stefan ZeuzemJames Witek
May 15, 2015·The Journal of Antimicrobial Chemotherapy·Joseph E RowerJennifer J Kiser
Jun 25, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Francesca LupoLucia De Franceschi
Jul 29, 2015·PloS One·Helen KovariUNKNOWN Swiss HIV Cohort Study
Dec 10, 2015·PloS One·Tarik AsselahFederico J Mensa
Jun 29, 2016·Journal of Clinical Pharmacology·Leah C JimmersonJennifer J Kiser
Jul 9, 2016·PloS One·Thomas KuntzenAndreas Geier
Dec 17, 2017·Tropical Medicine & International Health : TM & IH·E J SmoldersA Avihingsanon